Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study

Autor: Lodde, Georg C., Hassel, Jessica, Wulfken, Lena M., Meier, Friedegund, Mohr, Peter, Kähler, Katharina, Hauschild, Axel, Schilling, Bastian, Loquai, Carmen, Berking, Carola, Hüning, Svea, Eckardt, Julia, Gutzmer, Ralf, Reinhardt, Lydia, Glutsch, Valerie, Nikfarjam, Ulrike, Erdmann, Michael, Beckmann, Catharina L., Stang, Andreas, Kowall, Bernd, Galetzka, Wolfgang, Roesch, Alexander, Ugurel, Selma, Zimmer, Lisa, Schadendorf, Dirk, Forschner, Andrea, Livingstone, Elisabeth

Publikováno v: In European Journal of Cancer September 2023 191

Multicenter real-world data of adjuvant treatment and disease outcome of patients with melanoma with high-risk of recurrence

Autor: Livingstone, Elisabeth, Forschner, Andrea, Hassel, Jessica Cecile, Wulfken, Lena M., Meier, Friedegund Elke, Mohr, Peter, Kähler, Katharina C., Schilling, Bastian, Loquai, Carmen, Berking, Carola, Hüning, Svea, Eckardt, Julia, Gutzmer, Ralf, Reinhardt, Lydia, Kowall, Bernd, Galetzka, Wolfgang, Hauschild, Axel, Zimmer, Lisa, Schadendorf, Dirk, Lodde, Georg

Publikováno v: Journal of Clinical Oncology. 40:9570-9570

9570 Background: Clinical trials demonstrated a significantly improved recurrence-free survival (RFS) of melanoma patients treated adjuvantly with immune checkpoint inhibition (ICI) and targeted therapy (TT). As data from controlled trials are based

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::325db3c314242c701c1a0a4592afba82
https://doi.org/10.1200/jco.2022.40.16_suppl.9570

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels.

Autor: Wulfken, Lena M.¹, Moritz, Rudolf², Ohlmann, Carsten³, Holdenrieder, Stefan⁴, Jung, Volker³, Becker, Frank^3,5, Herrmann, Edwin², Walgenbach-Brünagel, Gisela⁵, Ruecker, Alexander von⁶, Müller, Stefan C.¹, Ellinger, Jörg¹ joerg.ellinger@ukb.uni-bonn.de

Publikováno v: PLoS ONE. 2011, Vol. 6 Issue 9, p1-7. 7p.

Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients.

Autor: Lodde G; Department of Dermatology, Venereology and Allergology, University Hospital Essen, 45147 Essen, Germany., Forschner A; Department of Dermatology, University Hospital Tuebingen, 72076 Tuebingen, Germany., Hassel J; Department of Dermatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Wulfken LM; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Venereology and Allergology, University Hospital Hannover Medical School, 30625 Hannover, Germany., Meier F; Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, 01307 Dresden, Germany., Mohr P; Department of Dermatology, Elbe Kliniken Stade-Buxtehude, 21614 Buxtehude, Germany., Kähler K; Department of Dermatology, Venereology and Allergology, University Hospital Kiel, 24105 Kiel, Germany., Schilling B; Department of Dermatology, Venereology and Allergology, University Hospital Wuerzburg, 97080 Wuerzburg, Germany., Loquai C; Department of Dermatology, University Hospital Mainz, 55131 Mainz, Germany., Berking C; Department of Dermatology, University Hospital Erlangen, CCC-Comprehensive Cancer Center Erlangen-EMN, Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Deutsches Zentrum Immuntherapie (DZI), 91054 Erlangen, Germany., Hüning S; Department of Dermatology, Klinikum Dortmund gGmbH, 44137 Dortmund, Germany., Schatton K; Department of Dermatology, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany., Gebhardt C; Department of Dermatology, Venereology and Allergology, University Hospital Hamburg, 20246 Hamburg, Germany., Eckardt J; Department of Dermatology, University Hospital Tuebingen, 72076 Tuebingen, Germany., Gutzmer R; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Venereology and Allergology, University Hospital Hannover Medical School, 30625 Hannover, Germany., Reinhardt L; Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, 01307 Dresden, Germany., Glutsch V; Department of Dermatology, Venereology and Allergology, University Hospital Wuerzburg, 97080 Wuerzburg, Germany., Nikfarjam U; Department of Dermatology, University Hospital Mainz, 55131 Mainz, Germany., Erdmann M; Department of Dermatology, University Hospital Erlangen, CCC-Comprehensive Cancer Center Erlangen-EMN, Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Deutsches Zentrum Immuntherapie (DZI), 91054 Erlangen, Germany., Stang A; Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, 45122 Essen, Germany., Kowall B; Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, 45122 Essen, Germany., Roesch A; Department of Dermatology, Venereology and Allergology, University Hospital Essen, 45147 Essen, Germany.; German Consortium for Translational Cancer Research (DKTK), Partner Site Essen and German Cancer Research Center (DKFZ), 45147 Essen, Germany., Ugurel S; Department of Dermatology, Venereology and Allergology, University Hospital Essen, 45147 Essen, Germany., Zimmer L; Department of Dermatology, Venereology and Allergology, University Hospital Essen, 45147 Essen, Germany., Schadendorf D; Department of Dermatology, Venereology and Allergology, University Hospital Essen, 45147 Essen, Germany.; German Consortium for Translational Cancer Research (DKTK), Partner Site Essen and German Cancer Research Center (DKFZ), 45147 Essen, Germany., Livingstone E; Department of Dermatology, Venereology and Allergology, University Hospital Essen, 45147 Essen, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2021 May 12; Vol. 13 (10). Date of Electronic Publication: 2021 May 12.